• 2008

Company Description

Chemo Wanbang Biopharma engages in the research and development, production, import, export, and sale of human interferon.

Shanghai Chemo Wanbang Biopharma Co. Ltd., with a registered capital of 105 Million RMB, is a joint-venture created in Nov, 19th 2008, from two renowned pharmaceutical companies: Clonbiotech with 70% of the shares and Chemo Group with 30% of the shares. Shanghai Chemo Wan Bang Biopharma Co. Ltd. is committed in Research & Development, Production and Sale of Human Interferon γ, Human Erythropoietin, Streptokinase and Pemetrexed Disodium and is engaging itself in the import and export of these products and respective technologies. Our manufacturing facilities counts 20.000 square meters divided into three workshops of API and two workshops of Finished products, all running with high technology equipments. We specialized ourselves in biotech products and antineoplastics agents.